Glioma stem cell invasion through regulation of the interconnected ERK, integrin α6 and N-cadherin signaling pathway.

[1]  D. Dinh,et al.  Transcriptional repression of Mad-Max complex by human umbilical cord blood stem cells downregulates extracellular signal-regulated kinase in glioblastoma. , 2012, Stem cells and development.

[2]  W. Kolch,et al.  ERK2 drives tumour cell migration in three-dimensional microenvironments by suppressing expression of Rab17 and liprin-β2 , 2012, Journal of Cell Science.

[3]  Olga Ilina,et al.  Interstitial guidance of cancer invasion , 2012, The Journal of pathology.

[4]  E. Ferro,et al.  Molecular Crosstalk between Integrins and Cadherins: Do Reactive Oxygen Species Set the Talk? , 2011, Journal of signal transduction.

[5]  D. Dinh,et al.  Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1 , 2011, Oncotarget.

[6]  A. Nalla,et al.  N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells. , 2011, Experimental cell research.

[7]  J. Rich,et al.  Seeing is Believing: Are Cancer Stem Cells the Loch Ness Monster of Tumor Biology? , 2011, Stem Cell Reviews and Reports.

[8]  C. Gondi,et al.  Regulation of Glioblastoma Progression by Cord Blood Stem Cells Is Mediated by Downregulation of Cyclin D1 , 2011, PloS one.

[9]  L. Taylor.  Diagnosis, treatment, and prognosis of glioma , 2010, Neurology.

[10]  Kwang-Hyun Cho,et al.  Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition. , 2010, Cancer Research.

[11]  Qiulian Wu,et al.  Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting , 2010, Protein & Cell.

[12]  U. Tepass,et al.  Adherens junctions: from molecules to morphogenesis , 2010, Nature Reviews Molecular Cell Biology.

[13]  M. Georgescu,et al.  Invasive glioblastoma cells acquire stemness and increased Akt activation. , 2010, Neoplasia.

[14]  R. McLendon,et al.  Integrin alpha 6 regulates glioblastoma stem cells. , 2010, Cell stem cell.

[15]  P. Marie,et al.  N-Cadherin Negatively Regulates Osteoblast Proliferation and Survival by Antagonizing Wnt, ERK and PI3K/Akt Signalling , 2009, PloS one.

[16]  Deric M. Park,et al.  Biology of glioma cancer stem cells , 2009, Molecules and cells.

[17]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[18]  Douglas W DeSimone,et al.  Cell adhesion receptors in mechanotransduction. , 2008, Current opinion in cell biology.

[19]  J. Sastre,et al.  The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFRamplification , 2008, Neuropathology : official journal of the Japanese Society of Neuropathology.

[20]  R. McLendon,et al.  Targeting cancer stem cells through L1CAM suppresses glioma growth. , 2008, Cancer research.

[21]  K. Gravdal,et al.  A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer , 2007, Clinical Cancer Research.

[22]  A. Kaye,et al.  Integrins: Molecular determinants of glioma invasion , 2007, Journal of Clinical Neuroscience.

[23]  Andre Fischer,et al.  N-Cadherin Regulates Cytoskeletally Associated IQGAP1/ERK Signaling and Memory Formation , 2007, Neuron.

[24]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[25]  M. Lisanti,et al.  N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. , 2007, Cancer research.

[26]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[27]  Angelo L. Vescovi,et al.  Brain tumour stem cells , 2006, Nature Reviews Cancer.

[28]  M. Takamura,et al.  MEK/ERK signaling is a critical mediator for integrin-induced cell scattering in highly metastatic hepatocellular carcinoma cells , 2006, Laboratory Investigation.

[29]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[30]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[31]  Qihong Zhou,et al.  Correlation of N-cadherin expression in high grade gliomas with tissue invasion , 2004, Journal of Neuro-Oncology.

[32]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[33]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[34]  A. Aplin,et al.  Integrin-Mediated Adhesion Regulates ERK Nuclear Translocation and Phosphorylation of Elk-1 , 2001, The Journal of cell biology.

[35]  M. Gujrati,et al.  Integrin α9β1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway. , 2012, Cellular signalling.

[36]  D. Gil,et al.  The inhibition of cell proliferation using silencing of N-cadherin gene by siRNA process in human melanoma cell lines. , 2012, Current medicinal chemistry.

[37]  G. Maki,et al.  Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. , 2007, International journal of radiation oncology, biology, physics.

[38]  K. Takakura,et al.  Expression and role of cadherins in astrocytic tumors , 2006, Brain Tumor Pathology.